Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Sponsor: MapLight Therapeutics
Summary
ML-007C-MA-212 is a 52-week open-label study designed to evaluate the long-term safety, tolerability, and effectiveness of ML-007C-MA in participants with schizophrenia who have recently completed an antecedent study (ML-007C-MA-211) or enroll directly (De Novo Cohort).
Official title: An Open-Label Study to Assess the Long-Term Safety, Tolerability, and Effectiveness of ML-007C-MA in Adult Participants With Schizophrenia
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
500
Start Date
2026-03-31
Completion Date
2030-02
Last Updated
2026-08-13
Healthy Volunteers
No
Conditions
Interventions
ML-007C-MA
ML-007C-MA dosed as 210/3 mg BID
Locations (41)
Clinical Site
Little Rock, Arkansas, United States
Clinical Site
Little Rock, Arkansas, United States
Clinical Site
Rogers, Arkansas, United States
Clinical Site
Bellflower, California, United States
Clinical Site
Cerritos, California, United States
Clinical Site
Culver City, California, United States
Clinical Site
Garden Grove, California, United States
Clinical Site
Lemon Grove, California, United States
Clinical Site
Long Beach, California, United States
Clinical Site
Los Angeles, California, United States
Clinical Site
Montclair, California, United States
Clinical Site
Oceanside, California, United States
Clinical Site
Orange, California, United States
Clinical Site
Pico Rivera, California, United States
Clinical Site
Riverside, California, United States
Clinical Site
San Diego, California, United States
Clinical Site
Sherman Oaks, California, United States
Clinical Site
Torrance, California, United States
Clinical Site
Hollywood, Florida, United States
Clinical Site
Hollywood, Florida, United States
Clinical Site
Miami, Florida, United States
Clinical Site
Miami Lakes, Florida, United States
Clinical Site
West Palm Beach, Florida, United States
Clinical Site
Atlanta, Georgia, United States
Clinical Site
Decatur, Georgia, United States
Clinical Site
Chicago, Illinois, United States
Clinical Site
Gaithersburg, Maryland, United States
Clinical Site
Boston, Massachusetts, United States
Clinical Site
Watertown, Massachusetts, United States
Clinical Site
Ann Arbor, Michigan, United States
Clinical Site
Las Vegas, Nevada, United States
Clinical Site
Marlton, New Jersey, United States
Clinical Site
New York, New York, United States
Clinical Site
Staten Island, New York, United States
Clinical Site
The Bronx, New York, United States
Clinical Site
North Canton, Ohio, United States
Clinical Site
West Chester, Ohio, United States
Clinical Site
Philadelphia, Pennsylvania, United States
Clinical Site
Austin, Texas, United States
Clinical Site
DeSoto, Texas, United States
Clinical Site
Richardson, Texas, United States